MENU
+Compare
INTS
Stock ticker: NASDAQ
AS OF
Dec 26, 10:40 AM (EDT)
Price
$0.40
Change
-$0.01 (-2.44%)
Capitalization
24.42M

INTS Intensity Therapeutics Forecast, Technical & Fundamental Analysis

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers... Show more

INTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for INTS with price predictions
Dec 24, 2025

INTS in +1.85% Uptrend, advancing for three consecutive days on December 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where INTS advanced for three days, in of 109 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on INTS as a result. In of 49 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for INTS turned negative on December 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 23 similar instances when the indicator turned negative. In of the 23 cases the stock turned lower in the days that followed. This puts the odds of success at .

INTS moved below its 50-day moving average on December 18, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

INTS broke above its upper Bollinger Band on December 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for INTS entered a downward trend on December 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.382) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (311.015).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
INTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

INTS is expected to report earnings to fall 16.67% to -5 cents per share on March 12

Intensity Therapeutics INTS Stock Earnings Reports
Q4'25
Est.
$-0.05
Q3'25
Est.
$-0.06
Q2'25
Beat
by $0.03
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.95
The last earnings report on November 07 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 345.33K shares outstanding, the current market capitalization sits at 24.42M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AJG260.772.07
+0.80%
Arthur J Gallagher & Co
AX88.910.51
+0.58%
Axos Financial
PESI12.67-0.07
-0.55%
Perma-Fix Environmental Services
IPM1.76-0.01
-0.56%
Intelligent Protection Management Corp
AMPX8.53-0.19
-2.18%
Amprius Technologies

INTS and Stocks

Correlation & Price change

A.I.dvisor tells us that INTS and INSM have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and INSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
-2.73%
INSM - INTS
30%
Poorly correlated
+0.37%
ACAD - INTS
28%
Poorly correlated
+0.14%
CCCC - INTS
27%
Poorly correlated
+2.97%
OABI - INTS
25%
Poorly correlated
+1.03%
GPCR - INTS
25%
Poorly correlated
-2.24%
More